4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Enveric Biosciences, Inc. (ENVB) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 5 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, ENVB reported $0M in revenue and ($9M) in net income.
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | — | $0M |
| Operating Income (EBIT) | ($9M) | ($10M) | ($18M) | ($20M) | — |
| Net Income | ($9M) | ($10M) | ($17M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $5M | $3M | $4M | $20M | — |
| Total Liabilities | $1M | $2M | $2M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ENVB viewer.
About TickerBase · Data methodology & sources